SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy (Q21560963)

From Wikidata

Jump to navigation Jump to search

scientific article

SMA CARNI-VAL TRIAL PART II: A Prospective, Single-Armed Trial of L-Carnitine and Valproic Acid in Ambulatory Children with Spinal Muscular Atrophy

Language	Label	Description	Also known as
English	SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy	scientific article	SMA CARNI-VAL TRIAL PART II: A Prospective, Single-Armed Trial of L-Carnitine and Valproic Acid in Ambulatory Children with Spinal Muscular Atrophy

Statements

scholarly article

0 references

SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy (English)

0 references

spinal muscular atrophy

1 reference

based on heuristic

inferred from title

muscular atrophy

1 reference

based on heuristic

inferred from title

Kristin J. Krosschell

object named as

Kristin J Krosschell

6

author given names

Kristin J

author last names

Krosschell

1 reference

28 August 2022

Louise R Simard

object named as

Louise R Simard

5

author given names

Louise R

author last names

Simard

1 reference

28 August 2022

Kathryn J Swoboda

17

object named as

Kathryn J Swoboda

author given names

Kathryn J

author last names

Swoboda

1 reference

28 August 2022

author name string

John T Kissel

1

author given names

John T

author last names

Kissel

1 reference

28 August 2022

Charles B Scott

2

author given names

Charles B

author last names

Scott

1 reference

28 August 2022

Sandra P Reyna

3

author given names

Sandra P

author last names

Reyna

1 reference

28 August 2022

Thomas O Crawford

4

author given names

Thomas O

author last names

Crawford

1 reference

28 August 2022

Gyula Acsadi

7

author given names

Gyula

author last names

Acsadi

1 reference

28 August 2022

Bakri Elsheik

8

author given names

Bakri

author last names

Elsheik

1 reference

28 August 2022

Mary K Schroth

9

author given names

Mary K

author last names

Schroth

1 reference

28 August 2022

Guy D'Anjou

10

author given names

Guy

author last names

D'Anjou

1 reference

28 August 2022

Bernard LaSalle

11

author given names

Bernard

author last names

LaSalle

1 reference

28 August 2022

Thomas W Prior

12

author given names

Thomas W

author last names

Prior

1 reference

28 August 2022

Susan Sorenson

13

author given names

Susan

author last names

Sorenson

1 reference

28 August 2022

Jo Anne Maczulski

14

author given names

Jo Anne

author last names

Maczulski

1 reference

28 August 2022

Mark B Bromberg

15

author given names

Mark B

author last names

Bromberg

1 reference

28 August 2022

Gary M Chan

16

author given names

Gary M

author last names

Chan

1 reference

28 August 2022

language of work or name

0 references

publication date

2011

0 references

0 references

6

0 references

7

0 references

e21296

0 references

copyright license

Creative Commons Attribution 4.0 International

6 July 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

19 March 2017

A positive modifier of spinal muscular atrophy in the SMN2 gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

19 March 2017

Phase II open label study of valproic acid in spinal muscular atrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

19 March 2017

Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

19 March 2017

A modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

19 March 2017

Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

19 March 2017

Population frequencies of inherited neuromuscular diseases—A world survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

19 March 2017

Identification and characterization of a spinal muscular atrophy-determining gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

7 April 2017

A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

7 April 2017

Adiposity is increased among high-functioning, non-ambulatory patients with spinal muscular atrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

12 September 2017

Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

12 September 2017

Increased fat mass and high incidence of overweight despite low body mass index in patients with spinal muscular atrophy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

12 September 2017

Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

12 September 2017

Literature review: health-related quality of life measurement in pediatric oncology: hearing the voices of the children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

12 September 2017

The survival of motor neurons protein determines the capacity for snRNP assembly: biochemical deficiency in spinal muscular atrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

12 September 2017

Natural history of denervation in SMA: relation to age, SMN2 copy number, and function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

12 September 2017

Review of the reliability and validity of myometry with children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

12 September 2017

Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

12 September 2017

Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

12 September 2017

A hungarian study on Werdnig-Hoffmann disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

12 September 2017

Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

12 September 2017

The role of histone acetylation in SMN gene expression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

27 September 2017

Valproic acid increases SMN levels in spinal muscular atrophy patient cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

27 September 2017

Correlation between severity and SMN protein level in spinal muscular atrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

27 September 2017

Spinal muscular atrophies: recent insights and impact on molecular diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

27 September 2017

Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

30 May 2018

The genetic component in child mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130730

30 May 2018

Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0021296

21 January 2018

Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0021296

21 January 2018

Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0021296

21 January 2018

Benefit of valproic acid in suppressing disease progression of ALS model mice

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0021296

21 January 2018

Valproic acid treatment in six patients with spinal muscular atrophy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0021296

21 January 2018

Epidemiology of neuromuscular disorders in the under-20 population in Bologna province, Italy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0021296

21 January 2018

Reliability of hand-held dynamometry in spinal muscular atrophy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0021296

21 January 2018

Reference values of maximum isometric muscle force obtained in 270 children aged 4–16 years by hand-held dynamometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/21754985

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Valproic Acid Promotes Neurite Outgrowth in PC12 Cells independent from Regulation of the Survival of Motoneuron Protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/21754985

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate

1 reference

https://pubmed.ncbi.nlm.nih.gov/21754985

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Valproate may improve strength and function in patients with type III/IV spinal muscle atrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21754985

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Establishing a standardized therapeutic testing protocol for spinal muscular atrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21754985

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0021296

0 references

2011PLoSO...621296K

0 references

release_jbir6bp2n5gqdoblb5ku5ey3cu

0 references

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q21560963&oldid=1869151645"